Medicine and Health
Cardiotoxicity Associated with Immune Checkpoint Inhibitors
S. Minegishi, N. Horita, et al.
Explore the serious side effects of immune checkpoint inhibitors in cancer treatment, focusing on the rare yet critical risk of cardiotoxicity. This insightful review by Shintaro Minegishi, Nobuyuki Horita, Tomoaki Ishigami, and Kiyoshi Hibi delves into the mechanisms, diagnosis, and management of this adverse event, shedding light on its connections with hypertension and atherosclerosis.
Related Publications
Explore these studies to deepen your understanding of the subject.

